(Q30304290)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

L H Brinckerhoff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

V V Kalashnikov

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L W Thompson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G V Yamshchikov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

R A Pierce

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H S Galavotti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C L Slingluff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

326-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

T cell priming versus T cell tolerance induced by synthetic peptides

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

Localization of aminopeptidase activity in freshly excised human skin: direct visualization by confocal laser scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

Solid-phase N-glycopeptide synthesis using allyl side-chain protected Fmoc-amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991029%2983%3A3%3C326%3A%3AAID-IJC7%3E3.0.CO%3B2-X

10.1002/(SICI)1097-0215(19991029)83:3<326::AID-IJC7>3.0.CO;2-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10495424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference